MNOV
Price
$1.35
Change
-$0.01 (-0.74%)
Updated
Aug 7, 04:06 PM (EDT)
Capitalization
66.7M
One day until earnings call
QLGN
Price
$1.84
Change
+$0.08 (+4.55%)
Updated
Aug 7, 04:29 PM (EDT)
Capitalization
2.88M
Interact to see
Advertisement

MNOV vs QLGN

Header iconMNOV vs QLGN Comparison
Open Charts MNOV vs QLGNBanner chart's image
Medicinova
Price$1.35
Change-$0.01 (-0.74%)
Volume$529
Capitalization66.7M
Qualigen Therapeutics
Price$1.84
Change+$0.08 (+4.55%)
Volume$300
Capitalization2.88M
MNOV vs QLGN Comparison Chart in %
Loading...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNOV vs. QLGN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOV is a Hold and QLGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (MNOV: $1.36 vs. QLGN: $1.76)
Brand notoriety: MNOV and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNOV: 46% vs. QLGN: 7%
Market capitalization -- MNOV: $66.7M vs. QLGN: $2.88M
MNOV [@Biotechnology] is valued at $66.7M. QLGN’s [@Biotechnology] market capitalization is $2.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNOV’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 1 green FA rating(s).

  • MNOV’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 1 green, 4 red.
According to our system of comparison, QLGN is a better buy in the long-term than MNOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNOV’s TA Score shows that 5 TA indicator(s) are bullish while QLGN’s TA Score has 3 bullish TA indicator(s).

  • MNOV’s TA Score: 5 bullish, 4 bearish.
  • QLGN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MNOV is a better buy in the short-term than QLGN.

Price Growth

MNOV (@Biotechnology) experienced а +0.74% price change this week, while QLGN (@Biotechnology) price change was -30.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Reported Earning Dates

MNOV is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNOV($66.7M) has a higher market cap than QLGN($2.88M). MNOV YTD gains are higher at: -35.238 vs. QLGN (-58.195). QLGN has higher annual earnings (EBITDA): -6.73M vs. MNOV (-12.72M). MNOV has more cash in the bank: 36.6M vs. QLGN (388K). MNOV has less debt than QLGN: MNOV (190K) vs QLGN (1.43M). MNOV (0) and QLGN (0) have equivalent revenues.
MNOVQLGNMNOV / QLGN
Capitalization66.7M2.88M2,318%
EBITDA-12.72M-6.73M189%
Gain YTD-35.238-58.19561%
P/E RatioN/A0.00-
Revenue00-
Total Cash36.6M388K9,433%
Total Debt190K1.43M13%
FUNDAMENTALS RATINGS
MNOV vs QLGN: Fundamental Ratings
MNOV
QLGN
OUTLOOK RATING
1..100
795
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
5997
P/E GROWTH RATING
1..100
10048
SEASONALITY SCORE
1..100
2150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (25) in the null industry is in the same range as MNOV (42) in the Biotechnology industry. This means that QLGN’s stock grew similarly to MNOV’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as MNOV (100) in the Biotechnology industry. This means that QLGN’s stock grew similarly to MNOV’s over the last 12 months.

MNOV's SMR Rating (96) in the Biotechnology industry is in the same range as QLGN (100) in the null industry. This means that MNOV’s stock grew similarly to QLGN’s over the last 12 months.

MNOV's Price Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for QLGN (97) in the null industry. This means that MNOV’s stock grew somewhat faster than QLGN’s over the last 12 months.

QLGN's P/E Growth Rating (48) in the null industry is somewhat better than the same rating for MNOV (100) in the Biotechnology industry. This means that QLGN’s stock grew somewhat faster than MNOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNOVQLGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 29 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLMN10.000.32
+3.31%
Hillman Solutions Corp
DOMH5.600.17
+3.13%
Dominari Holdings
GL141.231.72
+1.23%
Globe Life
LDI1.88-0.04
-2.08%
loanDepot
PTIX2.88-0.15
-5.11%
Protagenic Therapeutics Inc

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with NTLA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-7.37%
NTLA - QLGN
35%
Loosely correlated
-1.81%
PHIO - QLGN
32%
Poorly correlated
-0.85%
ZLDAF - QLGN
29%
Poorly correlated
N/A
MNOV - QLGN
28%
Poorly correlated
N/A
JAGX - QLGN
28%
Poorly correlated
-0.22%
More